 |
||||||||||||
|
Event Listings
The 3rd Annual European NeoAg Summit is the leading industry-dedicated meeting focused on advancing personalised cancer immunotherapy through neoantigen targeting. Over the last year, there has been a record number of neoantigen-based therapies heading into and through the clinic. In addition, exciting collaborations that bring significant investment into the space means that tumour-specific antigen targeting is set to explode. At the European NeoAg Summit, we bring together the leading pharma and biotech companies to discuss: -Reducing the discordance between various neoantigen prediction methods -Maximising the immune response to neoantigens -Shortening the needle-to-needle time of personalised cancer immunotherapy -Navigating the evolving regulatory landscape to faster approval Join the leaders from BioNTech, Genentech, Genocea, Gritstone Oncology, Agenus, Ziopharm, Vaccibody, the European Medicines Agency and many more to spur on more efficacious personalised cancer vaccines and cell therapies. URLs: Website https://go.evvnt.com/339791-0?pid=4870 Brochure https://go.evvnt.com/339791-2?pid=4870 Prices: Conference + 2 Workshops: EUR 3397.0, Conference + 1 Workshop: EUR 2898.0, Conference only: EUR 2399.0, Workshop Only (Each): EUR 599.0 Speakers: John Castle, Associate Vice President, Head of Translational Medicine and Bioinformatics, Agenus, Andrew Ishizuka, Chief Scientific Officer, Avidea Technologies, Mathias Vormehr, Head of Cancer Vaccines, BioNTech, Michal Bassani-Sternberg, Sternberg Director, Immunopeptidomics Unit Center of Experimental Therapeutics, CHUV, Asterios Tsiftsoglou, Committee for Advanced Therapies Member, European Medicines Agency, Lélia Delamarre, Senior Scientist, Cancer Immunology Research, Genentech, Jessica Flechtner, Chief Scientific Officer, Genocea, Jennifer Busby, Senior Director of Mass Spectrometry and Proteomics, Gritstone Oncology, Norbert Hilf, Director of Translational Development, Immatics, John Wang, Chief Executive Officer, IOVaxis, Trevor Clancy, Chief Scientific Officer, OncoImmunity, Sean Boyle, Director, Bioinformatics Applications, Personalis, Agnete Fredriksen, Chief Scientific Officer, Vaccibody, Laurence Cooper, Chief Executive Officer, Ziopharm, Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Michael Stein, Executive Chairman, Valo Therapeutics, Anna Pasetto, Assistant Professor, Karolinska Institutet Time: 8:00 am - 5:00 pm
Registration Website: https://go.evvnt.com/339791-1?pid=4870 Submitted by Love Evvnt, Evvnt on Tuesday, 23 April 2019 at 8:00 AM Category: Health Care & Medical |
||||||||||||
|
|
||||||||||||
 |
||||||||||||
|
Scoopasia v1.0b. Copyright © 2019
Today is Friday, 19 April 2019 |
||||||||||||
Want to get your press releases, event listings, and job ads on Scoopasia? 
| Journalist's Toolbox |  |
|
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!
(Instant Information Request) The easiest way to ask questions and request information from the PR community. Drill down, dig deep, for media information the way you want it. Resources and tools you can't do without. | |
| PR Tools |
|
Scoopasia Blog Search
Search the largest handpicked collection of Asia's most prominent and influential blogs. |
| Resources |
|
More Coming Soon... |
| Latest Jobs |
| Sorry, there are currently no entries posted here. |
